Harbor Investment Advisory’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Harbor Investment Advisory's LMAT Position: Q1 2026 in Review
Harbor Investment Advisory sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 615 shares — an estimated $49.9K sold.
Harbor Investment Advisory first reported a position in LMAT in Q3 2021 and held it in 18 quarters. The position peaked at $74.5K in Q3 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Harbor Investment Advisory reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
- Harbor Investment Advisory sold 615 LeMaitre Vascular shares in Q1 2026, an estimated $49.9K.
- Harbor Investment Advisory first reported a position in LeMaitre Vascular in Q3 2021 and held it in 18 quarters.
- Harbor Investment Advisory's LeMaitre Vascular position peaked at $74.5K in Q3 2024.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Harbor Investment Advisory's 13F filing for Q1 2026, filed 23 Apr 2026.